---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-23-005042"
form_type: "8-K"
ticker: "COSM"
cik: "0001474167"
company_name: "Cosmos Health Inc."
filed_at: "2023-07-06T23:59:59+00:00"
generated_at: "2026-06-13T11:40:28.469860+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Cosmos Health completes Cana buy for $1.67M; assets valued over $10M, expects gain

## Summary
- Purchase price $1.67M (€800k cash + $800k stock at $17.25/share) for 100% of Cana; closed June 30, 2023.
- Cana's tangible and intangible assets independently valued >$10M; Cosmos expects substantial gain on bargain purchase.
- Cana's 54,000 sq ft production facility added; prior acquisitions: Bikas GP (>$10M annual revenue) and ZipDoctor.
- Binding LOI for German-based Docpharm; projected to add $30M annual revenue by 2025.
- R&D clinical trials for obesity/weight management scheduled to start Q4 2023.

## SEC filing metadata
- accession: 0001477932-23-005042
- form_type: 8-K
- ticker: COSM
- cik: 0001474167
- company_name: Cosmos Health Inc.
- filed_at: 2023-07-06T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1474167/000147793223005042/0001477932-23-005042-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1474167/000147793223005042/cosm_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-23-005042
- JSON: https://secwatch.observer/filing/0001477932-23-005042.json
- Plain text: https://secwatch.observer/filing/0001477932-23-005042.txt

## Key facts
- M&A Transactions
  Cosmos Health Inc. completed an acquisition involving Pharmaceutical Laboratories CANA, S.A. for approximately $1.67 million (closed 2023-06-30).
  - Action: acquisition
  - Counterparty: Pharmaceutical Laboratories CANA, S.A.
  - Consideration: approximately $1.67 million
  - Closing: 2023-06-30
  source text: On June 30, 2023, Cosmos Health Inc. (the “Company”) completed the acquisition of one hundred (100%) percent of the equity of Pharmaceutical Laboratories CANA, S.A. (“Cana Holdings”). The Purchase Price for the shares was approximately $1.67 million consisting of €800,000 in cash and $800,000 in stock, based on an issuance price of $17.25 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1474167/000147793223005042/0001477932-23-005042-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.